FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 21 filers reported holding FREELINE THERAPEUTICS HLDGS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $19,569 | -5.5% | 43,005 | -1.4% | 0.00% | – |
Q4 2022 | $20,717 | -42.5% | 43,605 | -14.3% | 0.00% | – |
Q3 2022 | $36,000 | -39.0% | 50,905 | -25.2% | 0.00% | – |
Q2 2022 | $59,000 | -60.4% | 68,041 | -48.8% | 0.00% | – |
Q1 2022 | $149,000 | +84.0% | 132,822 | +223.4% | 0.00% | – |
Q4 2021 | $81,000 | -72.4% | 41,073 | -52.2% | 0.00% | -100.0% |
Q3 2021 | $293,000 | – | 85,959 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 1,361,064 | $24,853,000 | 7.00% |
Novo Holdings A/S | 2,361,229 | $43,116,000 | 1.85% |
Ally Bridge Group (NY) LLC | 425,000 | $7,761,000 | 1.33% |
TFG Asset Management GP Ltd | 750,000 | $13,695,000 | 0.92% |
SECTORAL ASSET MANAGEMENT INC | 657,494 | $12,006,000 | 0.85% |
FRAZIER MANAGEMENT LLC | 550,000 | $10,043,000 | 0.77% |
Eventide Asset Management | 2,485,656 | $44,266,000 | 0.68% |
Ovata Capital Management Ltd | 14,981 | $274,000 | 0.09% |
AXA S.A. | 551,476 | $10,070,000 | 0.03% |
Woodline Partners LP | 25,932 | $474,000 | 0.01% |